Hypothesis: A Tissue‑Specific Epigenetic‑Metabolic Rheostat Governs the Hierarchical Progression of Aging Hallmarks

Background and Rationale

The hallmarks of aging are organized as a causal cascade where primary lesions stimulate downstream dysfunctions, which finally impair tissue renewal and communication Cell 2013. This framework rejects a single master switch, yet it leaves room for a modulatory element that sets the gain of the cascade without being the origin of damage. Organ‑specific temporal signatures show that different tissues traverse the cascade at distinct speeds Nature 2020, suggesting a tunable rheostat that responds to local chromatin and metabolic cues.

Hypothesis

A tissue‑specific epigenetic‑metabolic rheostat, anchored in the nuclear lamina‑associated domain (LAD) landscape, dictates how fast primary hallmarks propagate into downstream antagonistic and integrative hallmarks. The rheostat does not create damage; it modulates the transcriptional response to existing lesions.

Mechanistic Basis

1. Lamina‑LAD tethering keeps large heterochromatin blocks at the nuclear periphery, limiting access of transcription factors to pro‑inflammatory and senescence‑associated loci.
2. With age, reduced lamin A/C levels and altered NAD+‑dependent sirtuin activity weaken this tether, releasing heterochromatin. Stochastic transcription of NF‑κB targets and SASP components rises, even when DNA lesion counts remain constant.
3. Detached chromatin also perturbs mitochondrial‑nuclear signaling: loss of NAD+ consumption at the lamina elevates cytosolic NAD+, activating SIRT3‑dependent deacetylation that paradoxically increases mitochondrial ROS production in certain tissues.
4. Because LAD composition reflects lineage‑specific transcription factor networks (e.g., HNF4A in liver, NEUROD2 in brain), the extent of tether loss varies by organ, producing the observed organ‑specific trajectories of aging.

Testable Predictions

• Prediction 1: Genome‑wide LAD occupancy, measured by DamID‑seq, will decline with age in a tissue‑matched pattern, and the slope of loss will correlate with the timing of p16^INK4a^ elevation and SASP secretion, independent of γH2AX foci counts.
• Prediction 2: Restoring lamin A/C levels in progeroid Ercc1^−/− mice via AAV will increase LAD‑H3K9me3 signals, lower circulating IL‑6 and mitochondrial superoxide, yet will not reduce the number of somatic mutations detected by whole‑genome sequencing.
• Prediction 3: Boosting NAD+ with NR or NMN in human iPSC‑derived colonic organoids will enhance lamin‑associated H3K9me3 marks, decrease NF‑κB p65 nuclear translocation, and reduce IL‑8 release, demonstrating a metabolic‑epigenetic feedback loop.
• Prediction 4: Tissue‑specific CRISPR‑mediated disruption of a lamina‑binding motif (e.g., deleting a LAD‑associated CTCF site) will accelerate local senescence markers without increasing overall DNA damage, confirming the rheostat’s causal role.

Potential Experiments

• Perform lamin B1 DamID‑seq on young (3 mo) and old (24 mo) mouse liver, kidney, and hippocampus; overlay with ATAC‑seq to detect newly accessible SASP promoters and with RNA‑seq to quantify IL‑1β, IL‑6, and CXCL1.
• Generate AAV9‑lamin A/C vectors; inject into Ercc1^−/− mice at 4 weeks; monitor frailty index, grip strength, and histological scoring of liver fibrosis and glomerular sclerosis at 16 weeks; parallel whole‑genome sequencing to verify mutation burden.
• Treat colonic organoids derived from healthy donors with 1 mM NR for 7 days; conduct ChIP‑seq for H3K9me3 at lamina‑associated regions identified by lamin B1 DamID; assay NF‑κB p65 nuclear intensity by imaging and quantify IL‑8 in supernatant via ELISA.
• Use CRISPR‑Cas9 to excise a conserved CTCF site flanking a lamin‑associated LAD in human fibroblast lines; assess SA‑β‑gal activity, SASP cytokine panel, and comet assay for DNA breaks after 10 days.

If the rheostat hypothesis holds, manipulating lamina‑LAD integrity or NAD+ levels will uncouple primary damage from downstream hallmarks, extending healthspan without altering mutation load. Conversely, if LAD remodeling fails to affect SASP or mitochondrial ROS while leaving genomic injury unchanged, the model would be falsified, reinforcing the view that aging emerges from a distributed network without a single upstream controller.